Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Real Brokerage | REAX | Nov 26, 2024 | 5.39 | -1.82 |
The Real Estate Select Sector SPDR Fund | XLRE | Nov 26, 2024 | 44.90 | +0.49 |
The RealReal | REAL | Nov 26, 2024 | 5.29 | -0.75 |
The RMR Group A | RMR | Nov 26, 2024 | 22.01 | -0.86 |
The Shyft Group | SHYF | Nov 26, 2024 | 14.29 | -0.42 |
The Trade Desk A | TTD | Nov 26, 2024 | 128.98 | -0.29 |
The9 ADR | NCTY | Nov 26, 2024 | 13.29 | +19.73 |
TherapeuticsMD | TXMD | Nov 26, 2024 | 1.40 | +0.72 |
Theratechnologies | THTX | Nov 26, 2024 | 1.22 | +1.67 |
Theravance Biopharma | TBPH | Nov 26, 2024 | 9.24 | -2.43 |
Theriva Biologics | TOVX | Nov 26, 2024 | 1.28 | -1.54 |
Thermo Fisher Scientific | TMO | Nov 26, 2024 | 512.98 | -0.24 |
Thermon Group | THR | Nov 26, 2024 | 31.73 | -1.58 |
Third Coast Bancshares | TCBX | Nov 26, 2024 | 36.00 | -0.58 |
Third Harmonic | THRD | Nov 26, 2024 | 12.93 | +3.94 |
Thomson Reuters | TRI | Nov 26, 2024 | 160.79 | +0.04 |
Thor Industries | THO | Nov 26, 2024 | 113.15 | -2.07 |
Thornburg Income Builder Opportunities Fund | TBLD | Nov 26, 2024 | 16.63 | -0.03 |
Thoughtworks | TWKS | Nov 26, 2024 | 4.47 | 0.00 |
ThredUp A | TDUP | Nov 26, 2024 | 1.52 | -5.00 |
Thryv | THRY | Nov 26, 2024 | 15.68 | +0.32 |
Thumzup Media | TZUP | Nov 26, 2024 | 3.95 | 0.00 |
Thunder Bridge Capital Partners IV SPAC A | THCP | Nov 26, 2024 | 11.35 | -0.39 |
Thunder Power | AIEV | Nov 26, 2024 | 0.25 | -6.58 |
Tian Ruixiang A | TIRX | Nov 26, 2024 | 1.69 | -2.87 |
Tidewater | TDW | Nov 26, 2024 | 50.17 | -3.82 |
Tigo Energy | TYGO | Nov 26, 2024 | 0.99 | -2.94 |
Tile Shop | TTSH | Nov 26, 2024 | 6.51 | -1.06 |
Tillys | TLYS | Nov 26, 2024 | 4.18 | +4.50 |
Tilray Brands | TLRY | Nov 26, 2024 | 1.36 | -4.23 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.